Get started
Author

Maria Dimopoulou

Observed names: Dimopoulou, Maria, M Dimopoulou, M Dimopoulou², M N Dimopoulou, M. Dimopoulou, M. N. Dimopoulou, M.N. Dimopoulou, MARIA N. DIMOPOULOU, MN Dimopoulou, Maria N Dimopoulou, Maria N. Dimopoulou
Observed institutions: University of Thessaly, Royal Free London NHS Foundation Trust, University of Milan, National and Kapodistrian University of Athens, The Royal Free Hospital, Laiko General Hospital of Athens, Children's Hospital Agia Sophia, University College London
ORCID: 0009-0001-0139-289X
Observed ORCID: 0009-0001-0139-289X
OpenAlex ID: A5103214143
Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma
2007 · Marie‐Christine Kyrtsonis, Theodoros P. Vassilakopoulos, et al. · British Journal of Haematology · 130
Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone with or Without Radiotherapy in Primary Mediastinal Large B-Cell Lymphoma: The Emerging Standard of Care
2012 · Theodoros P. Vassilakopoulos, Gerassimos A. Pangalis, et al. · The Oncologist · 127
Rituximab monotherapy is highly effective in splenic marginal zone lymphoma
2007 · C Kalpadakis, GA Pangalis, et al. · Hematological Oncology · 101
Treatment of Splenic Marginal Zone Lymphoma With Rituximab Monotherapy: Progress Report and Comparison With Splenectomy
2013 · Christina Kalpadakis, Gerassimos A. Pangalis, et al. · The Oncologist · 92
Waldenström's macroglobulinemia: clinical course and prognostic factors in 60 patients
2001 · M.-C. Kyrtsonis, T. Vassilakopoulos, et al. · Annals of Hematology · 88
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial
2022 · Ali T Taher, Maria Domenica Cappellini, et al. · The Lancet Haematology · 74
Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma.
2001 · T P Vassilakopoulos, G Nadali, et al. · PubMed · 72
Campath-1H (Anti-CD52) Monoclonal Antibody Therapy in Lymphoproliferative Disorders
2001 · G. A. Pangalis, M. N. Dimopoulou, et al. · Medical Oncology · 69
Incidence and Dynamics of Epstein-Barr Virus Reactivation After Alemtuzumab-Based Conditioning for Allogeneic Hematopoietic Stem-Cell Transplantation
2010 · Ben Carpenter, Tanzina Haque, et al. · Transplantation · 63
Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance
2018 · Christina Kalpadakis, Gerassimos A. Pangalis, et al. · Blood · 62
High Circulating Sclerostin is Present in Patients with Thalassemia-associated Osteoporosis and Correlates with Bone Mineral Density
2012 · E. Voskaridou, D. Christoulas, et al. · Hormone and Metabolic Research · 61
PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy
2015 · T P Vassilakopoulos, G A Pangalis, et al. · Leukemia · 52
The prognostic significance of beta(2)-microglobulin in patients with Hodgkin's lymphoma.
2002 · Theodoros P Vassilakopoulos, Gianpaolo Nadali, et al. · PubMed · 48
HLA-matched sibling stem cell transplantation in children with β-thalassemia with anti-thymocyte globulin as part of the preparative regimen: the Greek experience
2011 · E Goussetis, I Peristeri, et al. · Bone Marrow Transplantation · 46
Favorable outcome of primary cutaneous marginal zone lymphoma treated with intralesional rituximab
2006 · Maria‐Christina Kyrtsonis, Marina P. Siakantaris, et al. · European Journal Of Haematology · 46
PDF
B‐chronic lymphocytic leukemia: practical aspects
2002 · Gerassimos A. Pangalis, Theodoros P. Vassilakopoulos, et al. · Hematological Oncology · 45
The splenic form of mantle cell lymphoma
2002 · Maria K. Angelopoulou, Marina P. Siakantariz, et al. · European Journal Of Haematology · 45
Pityriasis rosea Associated with Imatinib (STI571, Gleevec)
2002 · K. Konstantopoulos, A. Papadogianni, et al. · Dermatology · 42
Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial
2025 · Ali T Taher, Hanny Al-Samkari, et al. · The Lancet · 36
Prognostic factors in advanced stage Hodgkin's lymphoma: the significance of the number of involved anatomic sites
2001 · T.P. Vassilakopoulos, M.K. Angelopoulou, et al. · European Journal Of Haematology · 36
Pregnancy in beta‐thalassemia intermedia: 20‐year experience of a Greek thalassemia center
2014 · Ersi Voskaridou, Angeliki Balassopoulou, et al. · European Journal Of Haematology · 34
Differential Diagnosis of Waldenström's Macroglobulinemia and Other B-Cell Disorders
2005 · Gerassimos A. Pangalis, Maria-Christina Kyrtsonis, et al. · Clinical Lymphoma · 34
Serum syndecan‐1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease
2004 · Maria‐Christina Kyrtsonis, Theodoros P. Vassilakopoulos, et al. · European Journal Of Haematology · 34
PDF
Successful Hematopoietic Stem Cell Transplantation in 2 Children with X-Linked Chronic Granulomatous Disease from Their Unaffected HLA-Identical Siblings Selected Using Preimplantation Genetic Diagnosis Combined with HLA Typing
2009 · Evgenios Goussetis, Christopher P. Konialis, et al. · Transplantation and Cellular Therapy · 31
Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP
2021 · Theodoros P. Vassilakopoulos, Michail Michail, et al. · The Oncologist · 29
PDF
Works count: 113
Citation count: 1,995
H-index: 27
I10-index: 49
Year
Topic
Type